Omvoh for Ulcerative Colitis: A Comprehensive Guide

Understanding Omvoh (mirikizumab-mrkz) for Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects millions worldwide, including many in India. It causes inflammation and ulcers in the digestive tract, primarily the large intestine (colon) and rectum. Symptoms can range from mild to severe and significantly impact a person's quality of life. Fortunately, advancements in medical science have led to new treatment options. One such medication is Omvoh (mirikizumab-mrkz), a prescription biologic drug approved for adults with moderate to severe ulcerative colitis.

This comprehensive guide aims to provide clear, practical information about Omvoh for Indian readers, covering its uses, how it works, dosage, potential side effects, and what to expect during treatment. We will also discuss important considerations like storage, missed doses, and when to seek medical advice.

What is Ulcerative Colitis?

Ulcerative colitis is characterized by inflammation and sores (ulcers) in the innermost lining of the colon and rectum. The exact cause of UC is not fully understood, but it is believed to involve a combination of genetic, immune system, and environmental factors. Symptoms can vary greatly among individuals and often occur in cycles, with periods of remission (symptoms are controlled) and flare-ups (symptoms worsen).

Common Symptoms of Ulcerative Colitis:

• Persistent diarrhea, often with blood or pus
• Abdominal pain and cramping
• Rectal bleeding
• Urgency to defecate
• Inability to defecate despite urgency
• Weight loss
• Fatigue
• Fever

How Does Omvoh Work?

Omvoh is a biologic medication, meaning it is made from living organisms. Its active ingredient, mirikizumab-mrkz, is a type of drug called an interleukin-17 (IL-17) receptor antagonist. In ulcerative colitis, the immune system mistakenly attacks the lining of the colon, leading to inflammation. IL-17 is a protein that plays a significant role in this inflammatory process. Omvoh works by blocking the action of IL-17, thereby reducing inflammation in the colon and helping to alleviate symptoms and achieve remission.

Omvoh: Dosage and Administration

Omvoh is administered in two ways: as an intravenous (IV) infusion and as a subcutaneous injection.

Induction Phase (Initial Treatment):

• The first three doses of Omvoh are typically given as an IV infusion.
• Each infusion lasts about 30 minutes and is administered in a hospital, clinic, or infusion center.
• You will receive your first infusion when Omvoh is prescribed, followed by another at week 4, and a third at week 8 of your treatment.
• The initial infusion dose is usually 300 milligrams (mg) in 15 milliliters (mL) of solution.

Maintenance Phase (Ongoing Treatment):

• After completing the induction phase, you will likely transition to subcutaneous injections.
• The maintenance dose is typically 200 mg given as an injection under the skin.
• These injections are usually administered every 4 weeks.
• The 200-mg injection is delivered using two single-use pens, meaning you will give yourself two injections per dose.
• Your doctor or a trained caregiver will show you or a family member how to administer these injections at home.
• The first home injection is typically given 4 weeks after your last IV infusion (which is 12 weeks after starting Omvoh).

Important Considerations Before Starting Omvoh

Before you begin treatment with Omvoh, your doctor will conduct several tests to ensure it is safe and appropriate for you.

Medical History and Tests:

• Liver Function Tests: Your doctor will likely perform blood tests to check your liver function before starting Omvoh. Liver function will be monitored regularly throughout your treatment, for at least 24 weeks after starting, and potentially even after you stop the medication.
• Infections: Omvoh can affect your immune system, potentially increasing your risk of infections. Your doctor will screen you for any active infections before you start treatment.
• Allergies: Inform your doctor about any known allergies to medications, especially Omvoh or its ingredients.
• Other Medical Conditions: Discuss any other health conditions you have, such as liver problems, or if you are pregnant, planning to become pregnant, or breastfeeding.

Potential Side Effects of Omvoh

Like all medications, Omvoh can cause side effects, ranging from mild to serious. It's important to be aware of these and report any concerns to your doctor promptly.

Common Mild Side Effects:

• Upper respiratory tract infections (e.g., common cold)
• Headache
• Fatigue
• Skin reactions (e.g., rash, itching)
• Nausea
• Joint pain

Serious Side Effects:

While less common, serious side effects can occur. Call your doctor right away if you experience any of the following:

• Severe Allergic Reactions: Symptoms may include hives, difficulty breathing, swelling of the face, lips, tongue, or throat. If you suspect a severe allergic reaction, call 911 or your local emergency number immediately.
• Serious Infections: Signs of infection can include fever, chills, cough, shortness of breath, or persistent sore throat.
• Liver Problems: Symptoms might include yellowing of the skin or eyes (jaundice), dark urine, or pain in the upper right abdomen.
• Changes in Immune System: Your doctor will monitor for potential changes.

Your doctor or pharmacist can provide a more detailed list of potential side effects and strategies to manage them.

Storage and Handling of Omvoh Injection Pens

Proper storage is crucial for maintaining the effectiveness of Omvoh injection pens.

• Store the pens in the refrigerator (2°C to 8°C or 36°F to 46°F).
• Do not freeze the pens.
• Before injecting, remove the pens from the refrigerator and let them sit at room temperature for about 30 minutes to allow the medication to warm up. This can make the injection more comfortable.
• Keep the pens in their original packaging to protect them from light.

What to Do If You Miss a Dose

If you miss a dose of your Omvoh injection at home:

• Inject the missed dose as soon as you remember.
• Then, inject your next dose 4 weeks after the missed dose.
• If you are unsure about what to do, consult your doctor or pharmacist.

Omvoh vs. Biosimilars

Omvoh is a biologic medication and is currently available only as a brand-name drug. It does not have a biosimilar version available. Biosimilars are similar to generic drugs but are made for biologic medications. While they have the same active ingredient core name, they have unique suffixes to distinguish them. The suffix “-mrkz” in mirikizumab-mrkz indicates that it is the specific brand-name drug and distinct from any future biosimilars.

When to Consult a Doctor

It is essential to maintain open communication with your healthcare provider throughout your treatment with Omvoh. Consult your doctor immediately if you:

• Experience any signs of a severe allergic reaction.
• Develop symptoms of a serious infection.
• Notice any signs of liver problems.
• Have concerns about any new or worsening symptoms of ulcerative colitis.
• Experience any side effects that are bothersome or do not go away.
• Have questions about your treatment, dosage, or administration.

Conclusion

Omvoh represents a significant advancement in the treatment of moderate to severe ulcerative colitis, offering a new hope for patients seeking better symptom control and improved quality of life. Understanding how Omvoh works, its administration, potential side effects, and storage instructions is crucial for effective and safe treatment. Always follow your doctor's advice and report any concerns promptly. With proper management and medical guidance, individuals with ulcerative colitis can work towards achieving remission and living a fuller life.